Developer docs
API playgroundTry for free, no card

Search company profiles

Daye

Full company profile

uuid0000b3s

Namestring
Daye
Legal namestring
Anne's Day Ltd
Websiteurl
yourdaye.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Daye (legal entity Anne's Day Ltd) is a London-based gynecological health company founded in 2017 that combines consumer period-care products with at-home diagnostic services for women and AFAB individuals. Its product platform is organized into three pillars: Vaginal Health (tampon-based microbiome screening, STI and HPV screening kits, ProViotics supplements, nurse consultations), Hormonal Health (at-home hormone testing covering thyroid, perimenopause, and fertility, plus the Period & Pelvic Pain Clinic), and Period Care (organic cotton and CBD-infused tampons, hemp pads, and bundles). Core technology includes a proprietary CBD tampon formulation clinically tested for safety (no TSS toxins, no irritation, no systemic toxicity) and ISO 13485/GMP-compliant manufacturing, with diagnostic samples processed by UKAS-accredited and CQC-registered laboratories.

The company operates a primarily DTC, product-led growth model via its e-commerce storefront (yourdaye.com) with localized versions across the UK, EU, and US, supplemented by subscription recurring deliveries (12-tampon plans from £6 with up to 20% multi-month discounts), a £5/20%-off referral programme, and a five-step ambassador programme. Distribution extends to premium retail (Liberty, Planet Organic, Oliver Bonas), corporate employee perks partnerships (Meta, Monzo), and a U.S. telehealth distribution agreement with Wisp. Daye is supported by EIC co-funding and publicly backs the NHS cervical cancer eradication goal by 2040, and is a member of the Women's Health Visibility Alliance coalition alongside Essity, Clue, Hertility, and Mooncup.

Total disclosed funding is approximately $17.1M across a 2019 seed led by Khosla Ventures ($5.5M, with Index Ventures and Kindred Capital) and a 2022 Series A led by Salica ($11.6M, with Cross-Border Impact Ventures, MMV Europe & Asia-Pacific, and Simplyhealth), plus a Google for Startups grant in 2018. The company is privately held, founder-led by Valentina Milanova, with Hannah Allen as Chief Medical Officer, and operates with a 11–50 person team. No revenue or ARR figures are disclosed in the source data.

Short descriptiontext

Daye is a London-based gynecological health company selling CBD/organic tampons, hemp pads, and at-home diagnostic screening kits (microbiome, STI, HPV, hormones) directly to women and AFAB consumers across the UK, EU, and US via e-commerce, subscriptions, retail, and corporate partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
women's health products, menstrual care, gynecological diagnostics, at-home screening kits, period care
Industry4 codes
1Feminine Hygiene Products (Pads, Tampons, Liners)
CodeCRADALAGPrimaryYes
2Tampons
CodeCRABAIACPrimaryNo
3Menstrual Pain Relief & Period Care Supplements
CodeCRABAIAJPrimaryNo
4Menstrual Pads (Reusable/Cloth)
CodeCRABAIABPrimaryNo
NAICS code2 codes
  • Sanitary Paper Product Manufacturing322291
  • Toilet Preparation Manufacturing32562
SIC code1 code
  • Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics2840
Product category
Women's Health and Menstrual Care Products
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Product Sales
TypeOne Time License
Description

Direct-to-consumer sales of period care products (tampons, pads), diagnostic screening kits, supplements (ProViotics), accessories, and educational books. One-time purchases available alongside subscription options.

yourdaye.com
2Subscription Revenue
TypeSubscription Recurring
Description

Recurring monthly deliveries of period products with multi-month discounts up to 20% off. Includes perks such as free cotton storage pouch, carbon-neutral deliveries, and free delivery in the UK.

yourdaye.com
3Diagnostic Services
TypeOne Time License
Description

At-home screening kits for vaginal microbiome, STIs, HPV, and hormone testing, with results interpreted by qualified healthcare professionals or through optional nurse consultations.

yourdaye.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
Pricing details2 tiers
112 tampons subscription starting at £6
ModelSubscriptionBilling cadenceMonthly
Notes

3-month tampon subscription with 12 tampons of choice for as little as £6, includes free tampon case

yourdaye.com
2Referral programme - £5 credit per referral
ModelOtherBilling cadencePay-as-you-go
Notes

For each successful referral where a friend makes their first purchase, the referrer earns £5 credit and the friend gets 20% off their first order

yourdaye.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1ProViotics
Description

Gut and vaginal microbiome supplements that are scientifically tested, freeze-dried, vegan, and allergen free.

yourdaye.com
+3 more records
Core offering1 text field

Daye manufactures and sells sustainable period care products, including organic and CBD-infused tampons and organic hemp pads, alongside at-home diagnostic screening kits for vaginal microbiome, STIs, HPV, and hormones. The company complements these products with ProViotics supplements, nurse-led clinical consultations, and value-added diagnostic bundles delivered via a direct-to-consumer e-commerce platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • CBD tampons demonstrated no negative impact on vaginal microbiome and increased levels of beneficial Lactobacillus bacteria
+2 more records
Product overview1 text field

Daye is a women's health company offering a comprehensive gynecological health platform comprising period care products and diagnostic screening services. The core offering includes organic and CBD-infused tampons and hemp pads for sustainable period care, alongside an expanding portfolio of at-home diagnostic tests (vaginal microbiome, STI, HPV, and hormone screening) with clinical consultation services. The platform is structured around three main product lines: Vaginal Health (screening kits and ProViotics supplements), Hormonal Health (hormone testing and fertility bundles), and Period Care (tampons, pads, and accessories). Value-added bundles combine diagnostic tests with consultations, while accessories like the Tampon Case and Vagina Matters educational book extend the ecosystem. The company positions itself as bridging the gender health gap through science-backed innovation.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1Women's Health Visibility Alliance
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2026-03-09
Description

Daye joined the Women's Health Visibility Alliance coalition alongside Essity, Clue, Hertility, and Mooncup to challenge systemic bias in digital platform content moderation that misclassifies women's health content as 'adult content' and restricts medically accurate information about menstruation, fertility, menopause, postpartum recovery, and sexual wellbeing.

independent.co.uk
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Planet Organic retails Daye products in their stores, providing distribution through the health food retailer channel.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Liberty London stocks Daye products, providing premium retail distribution for the brand.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Oliver Bonas retail stores carry Daye products, expanding brand presence to fashion-lifestyle retail locations.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Monzo offers Daye products as part of their employee perks and workplace benefits programme.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Meta offers Daye products as part of their company-wide employee perks.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Wisp, the largest pure-play women's telehealth platform in the U.S., partnered with Daye as part of a comprehensive virtual care ecosystem covering diagnostics, hormonal health, pelvic floor therapy, and nutrition counseling. This partnership expands Daye's reach in the U.S. market and integrates their diagnostic products into Wisp's platform.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Daye partnered with Fine Acts, a global creative nonprofit studio for social impact, to create and distribute the Vagina Matters educational book in the UK. Fine Acts works at the intersection of human rights and art, tech and science.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Daye

Women's Health and Menstrual Care Productsyourdaye.com

Daye is a London-based gynecological health company selling CBD/organic tampons, hemp pads, and at-home diagnostic screening kits (microbiome, STI, HPV, hormones) directly to women and AFAB consumers across the UK, EU, and US via e-commerce, subscriptions, retail, and corporate partnerships.

What Daye does

Daye (legal entity Anne's Day Ltd) is a London-based gynecological health company founded in 2017 that combines consumer period-care products with at-home diagnostic services for women and AFAB individuals. Its product platform is organized into three pillars: Vaginal Health (tampon-based microbiome screening, STI and HPV screening kits, ProViotics supplements, nurse consultations), Hormonal Health (at-home hormone testing covering thyroid, perimenopause, and fertility, plus the Period & Pelvic Pain Clinic), and Period Care (organic cotton and CBD-infused tampons, hemp pads, and bundles). Core technology includes a proprietary CBD tampon formulation clinically tested for safety (no TSS toxins, no irritation, no systemic toxicity) and ISO 13485/GMP-compliant manufacturing, with diagnostic samples processed by UKAS-accredited and CQC-registered laboratories.

The company operates a primarily DTC, product-led growth model via its e-commerce storefront (yourdaye.com) with localized versions across the UK, EU, and US, supplemented by subscription recurring deliveries (12-tampon plans from £6 with up to 20% multi-month discounts), a £5/20%-off referral programme, and a five-step ambassador programme. Distribution extends to premium retail (Liberty, Planet Organic, Oliver Bonas), corporate employee perks partnerships (Meta, Monzo), and a U.S. telehealth distribution agreement with Wisp. Daye is supported by EIC co-funding and publicly backs the NHS cervical cancer eradication goal by 2040, and is a member of the Women's Health Visibility Alliance coalition alongside Essity, Clue, Hertility, and Mooncup.

Total disclosed funding is approximately $17.1M across a 2019 seed led by Khosla Ventures ($5.5M, with Index Ventures and Kindred Capital) and a 2022 Series A led by Salica ($11.6M, with Cross-Border Impact Ventures, MMV Europe & Asia-Pacific, and Simplyhealth), plus a Google for Startups grant in 2018. The company is privately held, founder-led by Valentina Milanova, with Hannah Allen as Chief Medical Officer, and operates with a 11–50 person team. No revenue or ARR figures are disclosed in the source data.

Daye firmographics

Firmographics
Name
Daye
Legal name
Anne's Day Ltd
Website
https://yourdaye.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Daye is a London-based gynecological health company selling CBD/organic tampons, hemp pads, and at-home diagnostic screening kits (microbiome, STI, HPV, hormones) directly to women and AFAB consumers across the UK, EU, and US via e-commerce, subscriptions, retail, and corporate partnerships.
Ownership category
akta.pro rank

Daye industry classification

Industry
Product category
Women's Health and Menstrual Care Products
NAICS
Sanitary Paper Product Manufacturing (322291), Toilet Preparation Manufacturing (32562)
SIC
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)
akta.pro primary industry
Feminine Hygiene Products (Pads, Tampons, Liners) (CRADALAG)
akta.pro secondary industries
Tampons (CRABAIAC), Menstrual Pain Relief & Period Care Supplements (CRABAIAJ), Menstrual Pads (Reusable/Cloth) (CRABAIAB)

Keywords

  • Women's health products
  • Menstrual care
  • Gynecological diagnostics
  • At-home screening kits
  • Period care

Where Daye is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Daye business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Product Sales: Direct-to-consumer sales of period care products (tampons, pads), diagnostic screening kits, supplements (ProViotics), accessories, and educational books. One-time purchases available alongside subscription options.
  2. Subscription Revenue: Recurring monthly deliveries of period products with multi-month discounts up to 20% off. Includes perks such as free cotton storage pouch, carbon-neutral deliveries, and free delivery in the UK.
  3. Diagnostic Services: At-home screening kits for vaginal microbiome, STIs, HPV, and hormone testing, with results interpreted by qualified healthcare professionals or through optional nurse consultations.

Pricing tiers

ModelBillingPrice
SubscriptionMonthly12 tampons subscription starting at £6
OtherPay-as-you-goReferral programme - £5 credit per referral

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Daye product offering

Product offering

Core offering

Daye manufactures and sells sustainable period care products, including organic and CBD-infused tampons and organic hemp pads, alongside at-home diagnostic screening kits for vaginal microbiome, STIs, HPV, and hormones. The company complements these products with ProViotics supplements, nurse-led clinical consultations, and value-added diagnostic bundles delivered via a direct-to-consumer e-commerce platform.

Product overview

Daye is a women's health company offering a comprehensive gynecological health platform comprising period care products and diagnostic screening services. The core offering includes organic and CBD-infused tampons and hemp pads for sustainable period care, alongside an expanding portfolio of at-home diagnostic tests (vaginal microbiome, STI, HPV, and hormone screening) with clinical consultation services. The platform is structured around three main product lines: Vaginal Health (screening kits and ProViotics supplements), Hormonal Health (hormone testing and fertility bundles), and Period Care (tampons, pads, and accessories). Value-added bundles combine diagnostic tests with consultations, while accessories like the Tampon Case and Vagina Matters educational book extend the ecosystem. The company positions itself as bridging the gender health gap through science-backed innovation.

Differentiator

Problem solved

Functional benefit

Brands

  • ProViotics: Gut and vaginal microbiome supplements that are scientifically tested, freeze-dried, vegan, and allergen free.
  • Period & Pelvic Pain Clinic
  • Vagina Matters
  • Daye Club Referrals

Quantifiable outcome

  • CBD tampons demonstrated no negative impact on vaginal microbiome and increased levels of beneficial Lactobacillus bacteria
  • +2 more outcomes

Companies that use Daye

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Daye technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Daye partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Women's Health Visibility AlliancecoreGTM or Marketing Partner · 9 March 2026Daye joined the Women's Health Visibility Alliance coalition alongside Essity, Clue, Hertility, and Mooncup to challenge systemic bias in digital platform content moderation that misclassifies women's health content as 'adult content' and restricts medically accurate information about menstruation, fertility, menopause, postpartum recovery, and sexual wellbeing.
  • Planet OrganicminorChannel Partner/ Reseller/ DistributorPlanet Organic retails Daye products in their stores, providing distribution through the health food retailer channel.
  • LibertyminorChannel Partner/ Reseller/ DistributorLiberty London stocks Daye products, providing premium retail distribution for the brand.
  • Oliver BonasminorChannel Partner/ Reseller/ DistributorOliver Bonas retail stores carry Daye products, expanding brand presence to fashion-lifestyle retail locations.
  • MonzominorGTM or Marketing PartnerMonzo offers Daye products as part of their employee perks and workplace benefits programme.
  • MetaminorGTM or Marketing PartnerMeta offers Daye products as part of their company-wide employee perks.
  • WispcoreStrategic or Co-development PartnerWisp, the largest pure-play women's telehealth platform in the U.S., partnered with Daye as part of a comprehensive virtual care ecosystem covering diagnostics, hormonal health, pelvic floor therapy, and nutrition counseling. This partnership expands Daye's reach in the U.S. market and integrates their diagnostic products into Wisp's platform.
  • Fine ActscoreStrategic or Co-development PartnerDaye partnered with Fine Acts, a global creative nonprofit studio for social impact, to create and distribute the Vagina Matters educational book in the UK. Fine Acts works at the intersection of human rights and art, tech and science.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Daye competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Daye social profiles

Digital presence

Daye compliance and trust

Trust signal

Compliance4 records

Daye financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Daye leadership team

Management profile

Number of profiles

Profiles2 records

Daye funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Daye M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Daye

What does Daye do?

Daye manufactures and sells sustainable period care products, including organic and CBD-infused tampons and organic hemp pads, alongside at-home diagnostic screening kits for vaginal microbiome, STIs, HPV, and hormones. The company complements these products with ProViotics supplements, nurse-led clinical consultations, and value-added diagnostic bundles delivered via a direct-to-consumer e-commerce platform.

Is Daye a public or private company?

Daye is a private company. It is classified as venture growth investor backed and is currently operating.

When was Daye founded?

Daye was founded in 2017. It employs 11 to 50 people.

Where is Daye based?

Daye is headquartered in London, United Kingdom, in the Europe region.

How does Daye make money?

Three revenue lines are on record. Product Sales are the primary driver. The others are subscription Revenue and diagnostic Services.

Does Daye have an API?

No public API is recorded for Daye.

What industry is Daye in?

Daye's product category is Women's Health and Menstrual Care Products. Its primary akta.pro industry code is CRADALAG, Feminine Hygiene Products (Pads, Tampons, Liners), with a secondary code of CRABAIAC, Tampons. Its NAICS code is 322291 and its SIC code is 2840.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Express.co.ukGiant 13ft knickers spotted to highlight women's health issuesFemtech health brand Daye launched its national 'Discharge the Taboo' campaign on July 31 with a 13ft inflatable underwear installation at Cathedral Gardens in Manchester, aiming to tackle stigma surrounding vaginal discharge. A commissioned study of 1,000 women found that 25% are too embarrassed to flag discharge changes to their GP, potentially risking their health, while nearly half consider the topic taboo. Daye founder Valentina Milanova stated that better body literacy helps women recognise when something changes and seek medical advice appropriately.The Independent600 women’s health leaders warn social media platforms are censoring vital informationMore than 600 women's health leaders have signed an open letter warning that social media platforms are systematically censoring medically accurate information about menstruation, fertility, menopause, postpartum recovery, and sexual wellbeing by misclassifying posts as "adult content" and restricting them through automated moderation systems. A survey by the CensHERship campaign found 95% of women's health creators experienced censorship in the past year, with over half reporting they now self-censor their language to avoid being removed from platforms. Leading brands including Essity, Clue, Hertility, Daye, and Mooncup have formed the Women's Health Visibility Alliance coalition to challenge what campaigners describe as systemic bias in digital platform content moderation.HomepageUnlocking Hidden Revenue: Why Your Health Brand Should Accept FSA/HSA Payments Before Year-EndA Femtech Insider webinar featured Flex CEO Sam O'Keefe alongside founders from The Carry and Daye discussing how health brands can capture unused HSA/FSA funds by enabling these payment options at checkout. Brands implementing HSA/FSA payments through Flex report 50% higher average order values, up to 30% increases in checkout conversion, and 5-30% of total revenue from these payment methods. The article highlights that approximately $150 billion sits in HSA/FSA accounts with $4-8 billion expiring unused annually, while noting implementation can be completed in under a week on platforms like Shopify.TechCrunchStarting the tampon revolution with Valentina MilanovaTechCrunch's podcast 'Found' released an episode featuring Valentina Milanova, founder of the gynecological health company Daye. The discussion covers Daye's CBD-infused tampons, its competitive stance against established brands like Tampax, and insights into pitching to investors. The episode also highlights Milanova's approach to employee mental health and burnout prevention.MedCity NewsGynecological Health Startup Eyes US Launch with $11.5M in Series A FundingLondon-based gynecological health startup Daye has secured $11.5 million in Series A funding led by MassMutual Ventures and Hambro Perks to support its launch in the U.S. market in early 2023. The company, which offers products for period pain and at-home vaginal screening, plans to use the capital to expand its consumer reach and invest in research for conditions such as endometriosis and PCOS.EgirisimKadın sağlığı odaklı girişim Daye, 11.5 milyon euro yatırım aldıDaye, a women's health startup founded in London, secured 11.5 million euros in Series A funding led by Hambro Perks with participation from MassMutual Ventures and Cross Border Impact Ventures. The company plans to use the capital to expand its operations into the US market, where it intends to launch a tampon-based vaginal microbiome testing platform in early 2023.FinSMEsDaye Raises £10M in Series A FundingDaye, a gynaecological health startup based in London, UK, raised £10M in Series A funding to expand its product offerings. The funds will be used to launch a tampon-based at-home vaginal microbiome screening kit along with a digital platform for gynae health, and the company plans to enter the U.S. market. Founded in 2017, Daye has raised nearly £19m to date as it develops products for period pain and vaginal health.London TechWatchDaye Raises £10M to Make Gynaecological Health Top of Mind with the Tampon – London TechWatchDaye, a gynaecological health startup, has raised £10 million in a Series A funding round, bringing its total capital to £14.8 million. The company is simultaneously launching its Vaginal Microbiome Screen Service, an at-home diagnostic kit that uses tampons to detect conditions and connect users with pharmacists for treatment.Business InsiderThis period product company says it has developed the first flushable tampon wrapperDaye, a UK period product company, claims to have developed the world's first flushable tampon wrapper made from wood pulp. Its CBD tampons are lubricated with CBD extract and made from cottonized hemp, aiming to reduce plastic waste. The company also develops bamboo pads and is developing home vaginal health screening products.